PRPH251017C00002500 Option on ProPhase Labs
PRPH Stock | USD 0.40 0.03 8.11% |
PRPH251017C00002500 is a PUT option contract on ProPhase Labs' common stock with a strick price of 2.5 expiring on 2025-10-17. The contract was not traded in recent days and, as of today, has 87 days remaining before the expiration. The option is currently trading at an ask price of $0.7. The implied volatility as of the 22nd of July is 87.0.
A put option written on ProPhase Labs becomes more valuable as the price of ProPhase Labs drops. Conversely, ProPhase Labs' put option loses its value as ProPhase Stock rises.
Rule 16 of 2025-10-17 Option Contract
The options market is anticipating that ProPhase Labs will have an average daily up or down price movement of about 0.48% per day over the life of the option. With ProPhase Labs trading at USD 0.4, that is roughly USD 0.001933. If you think that the market is fully understating ProPhase Labs' daily price movement you should consider buying ProPhase Labs options at that current volatility level of 7.73%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Out Of The Money Call Option on ProPhase Labs
An 'Out of The Money' option on ProPhase has a strike price that ProPhase Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for ProPhase Labs' 'Out of The Money' options include buying the options if you expect a big move in ProPhase Labs' stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.
Call Contract Name | PRPH251017C00002500 |
Expires On | 2025-10-17 |
Days Before Expriration | 87 |
Delta | 0.922322 |
Vega | 2.88E-4 |
Gamma | 0.095018 |
Theoretical Value | 0.35 |
Open Interest | 285 |
Strike Price | 2.5 |
Current Price Spread | 0.0 | 0.7 |
Rule 16 Daily Up or Down | USD 0.001933 |
ProPhase short PUT Option Greeks
ProPhase Labs' Option Greeks for the contract ending on 2025-10-17 at a strike price of 2.5 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to ProPhase Labs' option greeks, its implied volatility helps estimate the risk of ProPhase Labs stock implied by the prices of the options on ProPhase Labs' stock.
Delta | 0.922322 | |
Gamma | 0.095018 | |
Theta | -0.001267 | |
Vega | 2.88E-4 | |
Rho | 5.2E-5 |
ProPhase long PUT Option Payoff at expiration
Put options written on ProPhase Labs grant holders of the option the right to sell a specified amount of ProPhase Labs at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of ProPhase Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on ProPhase Labs is like buying insurance aginst ProPhase Labs' downside shift.
Profit |
ProPhase Labs Price At Expiration |
ProPhase short PUT Option Payoff at expiration
By selling ProPhase Labs' put option, the investors signal their bearish sentiment. A short position in a put option written on ProPhase Labs will generally make money when the underlying price is above the strike price. Therefore ProPhase Labs' put payoff at expiration depends on where the ProPhase Stock price is relative to the put option strike price. The breakeven price of 2.85 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to ProPhase Labs' price. Finally, at the strike price of 2.5, the payoff chart is constant and positive.
Profit |
ProPhase Labs Price At Expiration |
ProPhase Labs Available Call Options
ProPhase Labs' option chain is a display of a range of information that helps investors for ways to trade options on ProPhase. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for ProPhase. It also shows strike prices and maturity days for a ProPhase Labs against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open Int | Strike Price | Current Spread | Last Price | |||
Call | PRPH251017C00007500 | 0 | 7.5 | 0.0 - 0.75 | 0.75 | |
Call | PRPH251017C00005000 | 0 | 5.0 | 0.0 - 0.75 | 0.75 | |
Call | PRPH251017C00002500 | 285 | 2.5 | 0.0 - 0.7 | 0.7 | Out |
Call | PRPH251017C00002000 | 0 | 2.0 | 0.0 - 0.8 | 0.8 | |
Call | PRPH251017C00001500 | 0 | 1.5 | 0.0 - 0.85 | 0.85 | |
Call | PRPH251017C00001000 | 191 | 1.0 | 0.0 - 0.05 | 0.05 | Out |
Call | PRPH251017C00000500 | 1321 | 0.5 | 0.05 - 0.15 | 0.1 | Out |
ProPhase Labs Corporate Management
Billy White | Consultant | Profile | |
Lance Bisesar | Corporate Controller | Profile | |
Robert Morse | Principal Controller | Profile | |
Stu Hollenshead | Chief Officer | Profile | |
Sergio Miralles | Executive Diagnostics | Profile | |
Kamal Obbad | Senior Genomics | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ProPhase Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ProPhase Labs. If investors know ProPhase will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ProPhase Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Earnings Share (2.23) | Revenue Per Share | Quarterly Revenue Growth (0.39) | Return On Assets |
The market value of ProPhase Labs is measured differently than its book value, which is the value of ProPhase that is recorded on the company's balance sheet. Investors also form their own opinion of ProPhase Labs' value that differs from its market value or its book value, called intrinsic value, which is ProPhase Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProPhase Labs' market value can be influenced by many factors that don't directly affect ProPhase Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProPhase Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if ProPhase Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProPhase Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.